Showing results (31-40 of 124) with videos related to
Sort By:
Pageof 13
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1994
Metastatic chordoma: pattern of spread and response to chemotherapyN Ashwood, P J Hoskin, M I SaundersInternational Journal of Radiation Oncology, Biology, Physics|July 1, 1990
The influence of extent and local management on the outcome of radiotherapy for brain metastasesP J Hoskin, J Crow, H T FordBreast Cancer Research and Treatment|January 1, 1992
Weight gain after primary surgery for breast cancer--effect of tamoxifenP J Hoskin, S Ashley, J R YarnoldEuropean Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Does long-term administration of tamoxifen affect bone mineral density?A J Neal, K Evans, P J HoskinJournal of Bone Oncology|August 16, 2024
Urinary biomarkers in metastatic bone pain: Results from a multicentre randomized trial of ibandronate compared to single dose radiotherapy for localized metastatic bone pain in prostate cancer (RIB)P J Hoskin, Aman Malhi, Krystyna Reczko, et al.The British Journal of Radiology|November 1, 1996
Short communication: a technique for delivering carbogen with high dose rate intraluminal brachytherapy in carcinoma of the oesophagus; early results and toxicityP J Hoskin, M E Powell, M I SaundersRadiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 1, 1996
Changes in applicator position with fractionated high dose rate gynaecological brachytherapyP J Hoskin, M Cook, D Bouscale, et al.The British Journal of Radiology|May 9, 2014
Image-guided high-dose-rate brachytherapy in inoperable endometrial cancerP Dankulchai, J Petsuksiri, Y Chansilpa, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|November 1, 1989
Hemibody irradiation (HBI) for metastatic bone pain in two histologically distinct groups of patientsP J Hoskin, H T Ford, C L HarmerThe British Journal of Radiology|October 26, 2007
Treatment planning and delivery of involved field radiotherapy in advanced Hodgkin's disease: results from a questionnaire-based audit for the UK Stanford V regimen vs ABVD clinical trial quality assurance programme (ISRCTN 64141244)P Diez, P J Hoskin, E G A AirdPageof 13